Company / Return on Assets (ROA)
Charles River Laboratories Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-2.0%
FY2025
5-year range
-2.0% / 4.8%
FY2021-FY2025
Trend
-796.6%
vs FY2024
Sector context
#101 of 158
Health Care
What the data says
Return on Assets (ROA) changed -797% YoY in FY2025, a notable deviation from the 9-year average annual change of -95%.
Based on SEC 10-K filings.
-2.0% in FY2025 with a 5-year CAGR of -6.1%.
Declined from 4.8% to -2.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -6.8pp
- 5-Year Change
- -6.1pp
- 10-Year Change
- -
Sector benchmark
#101 of 158 in Health CareTop 64% of 158This company -2.0% Sector average -2.3%
▼
+12.0% above sector average
Key checks
Key Insights
- Charles River Laboratories's return on assets (roa) has declined for 3 consecutive years.
- In FY2025, return on assets (roa) decreased 796.6% year-over-year.
- Currently 0.3pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -2.0% | -796.6% |
| FY2024 | 0.3% | -93.9% |
| FY2023 | 4.8% | -0.4% |
| FY2022 | 4.8% | +33.4% |
| FY2021 | 3.6% | -12.9% |
| FY2020 | 4.1% | +56.7% |
| FY2019 | 2.6% | -55.2% |
| FY2018 | 5.9% | +39.4% |
| FY2017 | 4.2% | -26.3% |
| FY2016 | 5.7% | +14.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026